FCAAIA Notes: So called “alternative” or “complementary” treatments are not necessarily bad. But, they are also not necessarily effective, especially as compared to medications that have under gone rigorous safety and efficacy evaluations before approval by the FDA. Proponents of alternative and complementary medicine often report their successes as anecdotes. But, as a well-known allergist once wrote, “The plural of anecdote is not data.” Whenever someone prescribes an FDA-approved medication or recommends a remedy that is not well studied, it is OK (and usually useful) to ask “Show me the data”. Then you can make an informed emotional decision based on science, not emotion. Continue reading “SHOULD DOCTORS EMBRACE OR REJECT ALTERNATIVE TREATMENTS?”
FCAAIA Notes: Twenty years ago the SMART study suggested a risk of long-acting beta agonists (LABA) use, However, the rail was associated with the use of LABA alone and NOT with the concurrent use of inhaled corticosteroids (ICS). Study after study shows that when used in combination with ICS, LABAs do not increase risk of asthma morbidity or mortality. Of course, the patients who need LABAs along with their ICS have more severe asthma to start with, so their risk is greater than those who do not require LABAs.
An important point is that many patients who use ICS/LABA combinations have never tried and ICS alone. Continue reading “REVISITING THE SAFETY OF LABAS IN CHILDREN WITH SEVERE ASTHMA”
FCAAIA Notes: There are many types of “eczema” so the term is more a description, than a diagnosis. Atopic dermatitis (AD) is the type of eczema studied in this paper.
AD is among other things a condition involving water loss from the skin (transepidermal water loss) resulting in dry skin. It is also a condition that might be thought of as a “rashy itch” rather than an “itchy rash.” That is, the itch precedes the rash. Continue reading “ECZEMA: DAILY “SOAK AND SMEAR” OR STEER CLEAR?”
FCAAIA Notes: There are only 2 proven and natural cures for airway allergy: Avoidance of the allergens and allergy shots. As effective as injections are, we recognize they are an inconvenience. Studies from many years ago show that in the long run, injections coast LESS than staying ion medications, particularly if you add in the indirect costs of illness such as lost time from work. But, when we talk about costs, we are talking about TOTAL costs (what you insurance company pays plus your out-of-pocket costs).
Unfortunately, the current state of medical insurance is that your co-pays and deductibles are higher and your insurance company pays less every year Continue reading “INADEQUATE HEALTH INSURANCE LEADS TO DISCONTINUATION OF SCIT”